Momentum Biotechnologies
Jeremiah Bowers is currently working as a Principal Scientist at Momentum Biotechnologies since October 2018. Prior to this, experienced as a Senior Scientist at the same company. Jeremiah also served as a Postdoctoral Scientist at Clemson University from February 2017 to July 2018, and as a Postdoctoral Fellow at Purdue University from March 2010 to April 2013. Their educational background includes a Doctor of Philosophy - PhD in Analytical Chemistry from Purdue University and a Bachelor of Science - BS in Chemistry from North Carolina State University.
Momentum Biotechnologies
Momentum Biotechnologies is a drug discovery partner that delivers innovative mass spec solutions to overcome research challenges for biopharma clients globally. Our core team of scientists and engineers started working together developing the RapidFire high-throughput MS platform and have been serving clients with MS-based services since 2004 including PureHoney Technologies (2015-23). Momentum Biotechnologies’ goal is to accelerate our partners’ drug discovery & development programs through superior mass spec based CRO services. We help clients identify and characterize leads for degraders, molecular glues, protein-protein interaction (PPI) disrupters, RNA binders and other target classes. We use innovative techniques including affinity selection MS (ASMS), intact mass MS, chemoproteomics and small & biomolecule analyses. We pride ourselves on rapid turnaround of the highest quality data, accelerating the momentum of our clients’ research projects. We have a large Mass Spec lab with 30+ instruments and a fully functional BL2 lab in Billerica, Massachusetts. For more information, please visit www.momentum.bio.